The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Human Atherosclerotic Plaque Alternative Macrophages Display Low Cholesterol Handling but High Phagocytosis Because of Distinct Activities of the PPARγ and LXRα Pathways
Open accessAbstract
Rationale: A crucial step in atherogenesis is the infiltration of the subendothelial space of large arteries by monocytes where they differentiate into macrophages and transform into lipid-loaded foam cells. Macrophages are heterogeneous cells that adapt their response to environmental cytokines. Th1 cytokines promote monocyte differentiation into M1 macrophages, whereas Th2 cytokines trigger an “alternative” M2 phenotype. Objective: We previously reported the presence of CD68 + mannose receptor (MR) + M2 macrophages in human atherosclerotic plaques. However, the function of these plaque CD68 + MR + macrophages is still unknown. Methods and Results: Histological analysis revealed that CD68 + MR + macrophages locate far from the lipid core of the plaque and contain smaller lipid droplets compared to CD68 + MR − macrophages. Interleukin (IL)-4–polarized CD68 + MR + macrophages display a reduced capacity to handle and efflux cellular cholesterol because of low expression levels of the nuclear receptor liver x receptor (LXR)α and its target genes, ABCA1 and apolipoprotein E, attributable to the high 15-lipoxygenase activity in CD68 + MR + macrophages. By contrast, CD68 + MR + macrophages highly express opsonins and receptors involved in phagocytosis, resulting in high phagocytic activity. In M2 macrophages, peroxisome proliferator-activated receptor (PPAR)γ activation enhances the phagocytic but not the cholesterol trafficking pathways. Conclusions: These data identify a distinct macrophage subpopulation with a low susceptibility to become foam cells but high phagocytic activity resulting from different regulatory activities of the PPARγ-LXRα pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this context, a study in macrophages has shown that engulfment of cellular debris relies on the availability of free fatty acids, which are released upon degradation of lipid droplets, thus linking effective lysis of lipid droplets with successful phagocytosis47.”
From Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain (2020) · cites this paper as [47]
In the citing paper
“It has recently been appreciated that PPARs act as master regulators governing the polarization of macrophages and microglia into “M2” or “alternative” activation states associated with the suppression of inflammation and promotion of phagocytosis and tissue repair (Chawla, 2010; Chinetti-Gbaguidi et al., 2011).”
From Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease (2012) · cites this paper as Chinetti-Gbaguidi et al., 2011
In the citing paper
“PPARγ activation has been shown to enhance the phagocytic capabilities of peripheral M2 polarized macrophages (Chinetti-Gbaguidi et al., 2011).”
From Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease (2012) · cites this paper as Chinetti-Gbaguidi et al., 2011
In the citing paper
“Thus, modulating microglial activation status by targeting nuclear receptors appears to restore the competence of these cells to phagocytose and clear amyloid in the AD brain (Mukundan et al., 2009; Chinetti-Gbaguidi et al., 2011).”
From Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease (2012) · cites this paper as Chinetti-Gbaguidi et al., 2011
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Warlow, C. P. (1991) · The Lancet · doi:10.1016/0140-6736(91)92916-p · Cited by 3,332
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107
Stein, M., Keshav, S., Harris, N., & Gordon, S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.287 · Cited by 1,960
Role of LXRs in control of lipogenesis
Schultz, J. R., Tu, H., Luk, A., Repa, J. J., Medina, J. C., Li, L., Schwendner, S., Wang, S., Thoolen, M., Mangelsdorf, D. J., et al. (2000) · Genes & Development · doi:10.1101/gad.850400 · Cited by 1,499
Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation
Vats, D., Mukundan, L., Odegaard, J. I., Zhang, L., Smith, K. L., Morel, C. R., Greaves, D. R., Murray, P. J., & Chawla, A. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.011 · Cited by 1,369
Bouhlel, M. A., Derudas, B., Rigamonti, E., Dièvart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.010 · Cited by 1,325
Self-citationNiemann-Pick C1 Disease Gene: Homology to Mediators of Cholesterol Homeostasis
Carstea, E. D., Morris, J. A., Coleman, K. G., Loftus, S. K., Zhang, D., Cummings, C., Gu, J., Rosenfeld, M. A., Pavan, W. J., Krizman, D. B., et al. (1997) · Science · doi:10.1126/science.277.5323.228 · Cited by 1,293
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170
Self-citation
Cited by
Sorted by citations
Items 201–300 of 391
Nuclear transport of STAT6 determines the matrix rigidity dependent M2 activation of macrophages
Kim, J.-K., Han, S., Park, S. I., Kim, I., & Kim, D. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121859 · Cited by 30
Becker, P. H., Thérond, P., & Gaignard, P. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108441 · Cited by 31
Faraj, A. A., Luciani, N., Kolosnjaj‐Tabi, J., Mattar, E. H., Clémеnt, O., Wilhelm, C., & Gazeau, F. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1516 · Cited by 29
HDL does not influence the polarization of human monocytes toward an alternative phenotype
Colin, S., Fanchon, M., Belloy, L., Bochem, A. E., Copin, C., Derudas, B., Stroes, E. S. G., Hovingh, G. K., Kuivenhoven, J. A., Dallinga‐Thie, G. M., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.168 · Cited by 29
Self-citationCao, H., Yu, F., Zhao, Y., Scianmarello, N., Lee, J., Dai, W., Jen, N., Beebe, T., Li, R., Ebrahimi, R., et al. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.11.059 · Cited by 29
Fu, S.-P., Wu, X.-C., Yang, R., Zhao, D., Cheng, J., Hu, Q., Ao, J., Zhang, Q., & Zhang, T. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115632 · Cited by 30
A Novel Macrophage Subpopulation Conveys Increased Genetic Risk of Coronary Artery Disease
Jiang, J., Hiron, T. K., Agbaedeng, T. A., Malhotra, Y., Drydale, E., Bancroft, J. M., Ng, E., Reschen, M. E., Davison, L. J., & O’Callaghan, C. A. (2024) · Circulation Research · doi:10.1161/circresaha.123.324172 · Cited by 32
Recent advances of lipid droplet-targeted AIE-active materials for imaging, diagnosis and therapy
Yuan, S., & Zhao, E. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116802 · Cited by 29
Bala, G., Baudhuin, H. V., Remory, I., Gillis, K., Debie, P., Krasniqi, A., Lahoutte, T., Raes, G., Devoogdt, N., Cosyns, B., et al. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1117-3 · Cited by 28
Friebel, J., Moritz, E., Witkowski, M., Jakobs, K., Strässler, E. T., Dörner, A., Steffens, D., Puccini, M., Lammel, S., Glauben, R., et al. (2021) · Cells · doi:10.3390/cells10123517 · Cited by 31
Zu, Y., Liu, Q.-F., Tian, S.-X., Jin, L., Jiang, F., Li, M., Zhu, B., & Ding, Z. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2790-3 · Cited by 29
Nuclear receptor mediated mechanisms of macrophage cholesterol metabolism
Nagy, Z. S., Czimmerer, Z., & Nagy, L. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.04.003 · Cited by 27
Xu, Q., Fu, R., Yin, G., Liu, X., Liu, Y., & Xiang, M. (2015) · Gene · doi:10.1016/j.gene.2015.12.039 · Cited by 28
Amelogenin induces M2 macrophage polarisation via PGE2/cAMP signalling pathway
Yamamichi, K., Fukuda, T., Sanui, T., Toyoda, K., Tanaka, U., Nakao, Y., Yotsumoto, K., Yamato, H., Taketomi, T., Uchiumi, T., et al. (2017) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2017.08.005 · Cited by 27
Molecular Pharmacology of Inflammation Resolution in Atherosclerosis
Kotlyarov, S. N., & Котлярова, А. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094808 · Cited by 31
de Gaetano, M., Alghamdi, K. S., Marcone, S., & Belton, O. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0060-9 · Cited by 27
Ikeda, H., Ishii, A., Sano, K., Chihara, H., Arai, D., Abekura, Y., Nishi, H., Ono, M., Saji, H., & Miyamoto, S. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.05.028 · Cited by 27
Cellular metabolism changes in atherosclerosis and the impact of comorbidities
Dai, Y., Junho, C. V. C., Schieren, L., Wollenhaupt, J., Sluimer, J. C., van der Vorst, E. P. C., & Noels, H. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1446964 · Cited by 27
Johnson, J. L., Shi, Y., Snipes, R., Janmohamed, S. G., Rolfe, T., Davis, B., Postle, A. D., & Macphee, C. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089034 · Cited by 26
Macrophage metabolic regulation in atherosclerotic plaque
Dolfi, B., Gallerand, A., Haschemi, A., Guinamard, R., & Ivanov, S. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.08.010 · Cited by 29
Electrochemical impedance spectroscopy to characterize inflammatory atherosclerotic plaques
Yu, F., Dai, X., Beebe, T., & Hsiai, T. K. (2011) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2011.09.007 · Cited by 28
Recent Advances in the Role of Immunity in Atherosclerosis
Fredman, G., & Spite, M. R. (2013) · Circulation Research · doi:10.1161/circresaha.113.302986 · Cited by 26
Cho, K. Y., Miyoshi, H., Nakamura, A., Greenberg, A. S., & Atsumi, T. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63153 · Cited by 25
Xu, J., Chen, C., & Yang, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.894879 · Cited by 25
PPARδ agonist GW0742 ameliorates Aβ1–42-induced hippocampal neurotoxicity in mice
An, Y., Zhang, C. T., Du, Y., Zhang, M., Tang, S. S., Hu, M. Y., Long, Y., Sun, H. B., & Hong, H. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9800-7 · Cited by 25
El‐Din, S. S., Elwahab, S. A., Rashed, L. A., Fayez, S., Aboulhoda, B. E., Heikal, O. A., Galal, A. F., & Nour, Z. A. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00741-4 · Cited by 25
Cao, L., Ding, L., Xia, Q., Zhang, Z., Li, M., Song, S., Yin, K., Li, Z., Li, X., Wang, Z., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07075-0 · Cited by 30
da Rocha, G. H. O., Loiola, R. A., Pantaleão, L. D. N., Reutelingsperger, C. P. M., Solito, E., & Farsky, S. H. P. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3433 · Cited by 24
Lipid‐based gene delivery to macrophage mitochondria for atherosclerosis therapy
Zakirov, F., Zhang, D., Grechko, A. V., Wu, W., Poznyak, A. V., & Orekhov, A. N. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.584 · Cited by 24
Wang, W., Du, L., Wei, Q., Lu, M., Xu, D., & Li, Y. (2025) · Antioxidants · doi:10.3390/antiox14040476 · Cited by 23
M1/M2 macrophage-targeted nanotechnology and PROTAC for the treatment of atherosclerosis
Ma, Y., Yang, X., Ning, K., & Guo, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122811 · Cited by 23
Lee‐Rueckert, M., Lappalainen, J., Leinonen, H., Plihtari, R., Nordström, T., Åkerman, K. E. O., Öörni, K., & Kovanen, P. T. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.08.011 · Cited by 21
Belcastro, E., Franzini, M., Cianchetti, S., Lorenzini, E., Masotti, S., Fierabracci, V., Pucci, A., Alfonso Pompella, C., & Corti, A. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0687-6 · Cited by 21
Meletta, R., Steier, L., Borel, N., Mu, L., Keller, C., Chiotellis, A., Russo, E., Halin, C., Ametamey, S. M., Schibli, R., et al. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-0987-0 · Cited by 21
Sonodynamic therapy for the treatment of atherosclerosis
Zhang, Y., Yang, Y. H., Feng, Y., Gao, X., Pei, L., Li, X., Gao, B., Liu, L., Wang, C., & Gao, S. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.11.016 · Cited by 20
Sun, H., Jiang, J., Gong, L., Li, X., Yang, Y., Luo, Y., Guo, Z.-Z., Lu, R., Li, H., Li, J., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109352 · Cited by 20
Nitroxyl (HNO) reduces endothelial and monocyte activation and promotes M2 macrophage polarization
Andrews, K. L., Sampson, A. K., Irvine, J. C., Shihata, W., Michell, D. L., Lumsden, N. G., Lim, C., Huet, O., Drummond, G. R., Kemp‐Harper, B. K., et al. (2016) · Clinical Science · doi:10.1042/cs20160097 · Cited by 19
New insights into macrophage subsets in atherosclerosis
Wang, Y., Wang, Q. A., & Xu, D. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02224-0 · Cited by 19
Functional diversity of macrophages in vascular biology and disease
Park, I., Kassiteridi, C., & Monaco, C. G. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.10.005 · Cited by 19
Single‐Cell Mechanical Characterization of Human Macrophages
Evers, T. M. J., Sheikhhassani, V., Tang, H., Haks, M. C., Ottenhoff, T. H. M., & Mashaghi, A. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100133 · Cited by 18
Wilson, H. M. (2022) · Biochemical Society Transactions · doi:10.1042/bst20220441 · Cited by 18
Faraj, A. A. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1797-9 · Cited by 18
Atherogenic lipids and macrophage subsets
Getz, G. S., & Reardon, C. A. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000217 · Cited by 19
Ni, J., Zhou, L., Ding, L. J., Zhang, X., Zhao, X., Li, H., Cao, H., Liu, S., Wang, Z., Ma, R., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1440 · Cited by 17
Chen, S.-Y., Chen, Y., Lee, Y.-J., Jiang, C., Lu, S., & Lin, F. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108575 · Cited by 17
Qian, Z., Yang, H., Li, H., Liu, C., Yang, L., Qu, Z., & Li, X. (2021) · Biomedicines · doi:10.3390/biomedicines9091150 · Cited by 17
Cadherin-11 Regulates Macrophage Development and Function
To, S., Chavula, T., Pedroza, M., Smith, J., & Agarwal, S. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.795337 · Cited by 17
Mechanoimmunology: Are inflammatory epigenetic states of macrophages tuned by biophysical factors?
Jain, N., Lord, J. M., & Viola Vogel, B. (2022) · APL Bioengineering · doi:10.1063/5.0087699 · Cited by 17
Wouters, K., Cudejko, C., Gijbels, M. J., Fuentes, L., Bantubungi, K., Vanhoutte, J., Dièvart, R., Paquet, C., Bouchaert, E., Hannou, S. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032440 · Cited by 19
Self-citationAdamson, S. E., Polanowska‐Grabowska, R., Marqueen, K. E., Griffiths, R., Angdisen, J. J., Breevoort, S. R., Schulman, I. G., & Leitinger, N. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310467 · Cited by 16
Macrophage Subsets in Human Atherosclerosis
Finn, A. V., Saeed, O., & Virmani, R. (2012) · Circulation Research · doi:10.1161/circresaha.112.268714 · Cited by 17
Packard, R. R. S., Zhang, X., Luo, Y., Ma, T., Jen, N., Ma, J., Demer, L. L., Zhou, Q., Sayre, J. W., Li, R., et al. (2016) · Annals of Biomedical Engineering · doi:10.1007/s10439-016-1559-9 · Cited by 15
Potì, F., Scalera, E., Feuerborn, R., Fischer, J., Arndt, L., Varga, G., Pardali, E., Seidl, M. D., Fobker, M., Liebisch, G., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.158127 · Cited by 15
Heat‐killed Staphylococcus aureus reduces atherosclerosis by inducing anti‐inflammatory macrophages
Frodermann, V., van Duijn, J., van Puijvelde, G. H. M., van Santbrink, P. J., Lagraauw, H. M., de Vries, M. R., Quax, P. H. A., Bot, I., Foks, A. C., de Jager, S. C. A., et al. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12484 · Cited by 15
He, X., Wang, L., Chen, X., Liang, Q., Wang, W., Lin, A., Yi, L., Wang, Y., & Gao, Q. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000333 · Cited by 15
Zhang, X., Xiao, S., & Li, Q. (2018) · Journal of International Medical Research · doi:10.1177/0300060518787671 · Cited by 15
Spear, R., Boytard, L., Blervaque, R., Chwastyniak, M., Hot, D., Vanhoutte, J., Lamblin, N., Amouyel, P., & Pinet, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215499 · Cited by 15
Self-citationNishida, S., Matsumura, T., Senokuchi, T., Murakami-Nishida, S., Ishii, N., Morita, Y., Yagi, Y., Motoshima, H., Kondo, T., & Araki, E. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.027 · Cited by 15
Mogilenko, D. A., Danko, K. V., Larionova, E. E., Shavva, V. S., Кудрявцев, И. В., Nekrasova, E. V., Burnusuz, A., Gorbunov, N., Trofimov, A. V., Zhakhov, A. V., et al. (2022) · Immunology and Cell Biology · doi:10.1111/imcb.12534 · Cited by 19
Advances in stimulus-responsive nanomedicine for treatment and diagnosis of atherosclerosis
Mao, J., Wu, C., Zheng, L., Li, Y., Yang, R., Yuan, P., Jiang, J., Li, C., & Zhou, X. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114298 · Cited by 14
Yang, J.-M., Lee, H. S., Seo, J. H., Park, J., Gelman, I. H., Lo, E. H., & Kim, K. (2017) · Scientific Reports · doi:10.1038/srep42723 · Cited by 14
Anti-atherosclerotic effects of LXRα agonist through induced conversion of M1 macrophage to M2.
Dou, F., Chen, J., Cao, H., Jia, Q., Shen, D., Liu, T., & Chen, C. (2019) · PubMed · Cited by 13
The role of macrophage polarization in vascular calcification
Li, D., Chu, F., Li, X., & Zhao, L. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149863 · Cited by 13
Targeting monocyte and macrophage subpopulations for immunotherapy: a patent review (2009 – 2013)
Jackson, W. D., & Woollard, K. J. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.914495 · Cited by 12
Liu, M., Yang, W., Liu, S., Hock, D., Zhang, B., Huo, Y. R., Tong, X., & Yan, H. (2018) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2017.1288740 · Cited by 12
Biological role of GITR/GITRL in attributes and immune responses of macrophage
Fu, Z., Wang, S., Li, J., Zhang, Y., Li, H., Li, G., Wan, X., & Zhang, Y. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0919-387rr · Cited by 12
Liver X Receptor α-Dependent Iron Handling in M2 Macrophages
Hasty, A. H., & Yvan‐Charvet, L. (2013) · Circulation Research · doi:10.1161/circresaha.113.302613 · Cited by 13
Ji, M., Mao, L., Wei, Y., Zhu, B., Zhai, Y., Zhou, X., Tao, W., Wang, W., & Wu, H. (2024) · Journal of physiological investigation. · doi:10.4103/ejpi.ejpi-d-23-00040 · Cited by 11
Zhao, S., Guo, H., Qiu, L., Zhong, C., Xue, J., Qin, M., Zhang, Y., Xu, C., Xie, Y., & Yu, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-61209-w · Cited by 11
Zou, D., Yang, P., Liu, J., Dai, F., Xiao, Y., Zhao, A., & Huang, N. (2023) · Advanced Biology · doi:10.1002/adbi.202200277 · Cited by 11
Neuro-immune axis in atherosclerosis: mechanisms of regulation and therapeutic opportunities
Shang, Y., Pan, Y., Xie, L., Zhao, Y. G., Mao, W., & Chen, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1619338 · Cited by 11
Sandhu, A., Rawat, K., Gautam, V., Kumar, A., Sharma, A., Bhatia, A., Grover, S., Saini, L. K., & Saha, L. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111126 · Cited by 11
Defective macrophage efferocytosis in advanced atherosclerotic plaque and mitochondrial therapy
Li, W., Huang, Y., Liu, J., Zhou, Y., Sun, H., Fan, Y., & Liu, F. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123204 · Cited by 12
ABCG1: Not as good as expected?
Goff, W. L., & Dallinga‐Thie, G. M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.015 · Cited by 10
Zago, V. H. D. S., Scherrer, D. Z., Parra, E. S., Panzoldo, N. B., Alexandre, F., Nakandakare, E. R., Quintão, E. C. R., & de Faria, E. C. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3823-0 · Cited by 10
Role of the liver X receptors in skin physiology: Putative pharmacological targets in human diseases
Ouedraogo, Z. G., Fouache, A., Trousson, A., Baron, S., & Lobaccaro, J. A. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.02.006 · Cited by 10
Shimizu, Y., Hanzawa, H., Zhao, Y., Fukura, S., Nishijima, K., Sakamoto, T., Zhao, S., Tamaki, N., Ogawa, M., & Kuge, Y. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-1036-8 · Cited by 10
Fadini, G. P., & Ciciliot, S. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu144 · Cited by 10
Protective Role for Myeloid Specific KLF2 in Atherosclerosis
Shaked, I., & Ley, K. F. (2012) · Circulation Research · doi:10.1161/circresaha.112.270991 · Cited by 10
Oxysterols in tumor immune microenvironment (TIME)
Liu, Y., Qin, J., Li, X., & Wu, G. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106634 · Cited by 9
Activation of chicken macrophages during in vitro stimulation and expression of immune genes
Jin, X. Y., Zhang, X., Li, J., Yu, W., & Chen, F. (2018) · American Journal of Veterinary Research · doi:10.2460/ajvr.79.12.1306 · Cited by 9
Shimizu, Y., Motomura, A., Takakura, H., Tamaki, N., Kuge, Y., & Ogawa, M. (2019) · Annals of Nuclear Medicine · doi:10.1007/s12149-019-01332-1 · Cited by 9
Duraisamy, P., Ravi, S., Krishnan, M., Martin, L. C., Manikandan, B., Koodalingam, A., & Ramar, M. (2020) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/1871525718666201217163207 · Cited by 9
Liu, N., Zhang, B., Sun, Y., Song, W., & Guo, S.-D. (2021) · Vessel Plus · doi:10.20517/2574-1209.2021.25 · Cited by 10
Differences in forward angular light scattering distributions between M1 and M2 macrophages
Halaney, D. L., Zahedivash, A., Phipps, J. E., Wang, T., Dwelle, J. C., Saux, C. J. L., Asmis, R., Milner, T. E., & Feldman, M. D. (2015) · Journal of Biomedical Optics · doi:10.1117/1.jbo.20.11.115002 · Cited by 9
Transducin‐like enhancer of split‐1 is expressed and functional in human macrophages
Paoli, F. D., Copin, C., Vanhoutte, J., Derudas, B., Vinod, M., Zawadzki, C., Susen, S., Pattou, F. N., Haulon, S., Staels, B., et al. (2015) · FEBS Letters · doi:10.1002/1873-3468.12029 · Cited by 10
Self-citationMyeloid BAF60a deficiency alters metabolic homeostasis and exacerbates atherosclerosis
Zhao, Y., Liu, Y., Zhao, G., Lu, H., Liu, Y., Xue, C., Chang, Z., Liu, H., Deng, Y., Liang, W., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113171 · Cited by 9
Das, A. A., Choudhury, K. R., Jagadeeshaprasad, M. G., Kulkarni, M. J., Mondal, P. C., & Bandyopadhyay, A. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103796 · Cited by 8
Suchy, D., Łabuzek, K., Machnik, G., & Okopień, B. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-0982-4 · Cited by 8
The Bidirectional Relationship between Cholesterol and Macrophage Polarization
Medbury, H. J. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000303 · Cited by 8
Yin, W., Wang, J., Li, L., Zheng, H., & Xu, S. (2024) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-024-10579-7 · Cited by 7
Li, H., Huang, Z., & Zeng, F. (2022) · Molecules · doi:10.3390/molecules27248639 · Cited by 7
Boehme, J. D., Pietkiewicz, S., Lavrik, I. N., Jeron, A., & Bruder, D. (2015) · Lung · doi:10.1007/s00408-015-9797-4 · Cited by 7
Effect of Topographical Feature Size on the Trend of Cell Behaviors
Kim, H. N., & Kim, J. (2017) · IEEE Transactions on Nanotechnology · doi:10.1109/tnano.2017.2771311 · Cited by 7
Lee, W., Lim, Y. G., Song, Y. J., & Park, K. (2024) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-024-00101-w · Cited by 6
The association and application of sonodynamic therapy and autophagy in diseases
Chen, F., Xue, Q., He, N., Zhang, X., Li, S., & Zhao, C. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122215 · Cited by 6
Nardo, L., Rezzani, R., Facchetti, L., Favero, G., Franco, C., Abdelhafez, Y. G., Badawi, R. D., Guindani, M., Seo, Y., & Pampaloni, M. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082920 · Cited by 6
Understanding the role of alternative macrophage phenotypes in human atherosclerosis
Kawai, K., Vozenilek, A. E., Kawakami, R., Sato, Y., Ghosh, S., Virmani, R., & Finn, A. V. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2111301 · Cited by 6
Pan, J., Cai, Y., Wu, J., Lu, Y., & Li, Z. (2023) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2023.107514 · Cited by 6
Ravi, S., Martin, L. C., Krishnan, M., Kumaresan, M., Manikandan, B., & Ramar, M. (2023) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2023.105362 · Cited by 6
Metadata
- Authors
- Chinetti-Gbaguidi, G., Baron, M., Bouhlel, M. A., Vanhoutte, J., Copin, C., Sebti, Y., Derudas, B., Mayi, T., Bories, G., Tailleux, A., Haulon, S., Zawadzki, C., Jude, B., & Staels, B.
- Affiliations
- From Univ Lille Nord de France (G.C.-G., M.B., M.A.B., J.V., C.C., Y.S., B.D., T.M., G.B., A.T., C.Z., B.J., B.S.), F-59000, Lille; Inserm (G.C.-G., M.B., M.A.B., J.V., C.C., Y.S., B.D., T.M., G.B., A.T., B.S.), U1011, F-59000, Lille; UDSL (G.C.-G., M.B., M.A.B., J.V., C.C., Y.S., B.D., T.M., G.B., A.T., C.Z., B.J., B.S.), F-59000, Lille, France; Institut Pasteur de Lille (G.C.-G., M.B., M.A.B., J.V., C.C., Y.S., B.D., T.M., G.B., A.T., B.S.), F-59019, Lille; and EA2693 and Centre Hospitalier...
- Inserm (FR)
- ORCID
- Venue
- Circulation Research
- Published
- 2011-04-15
- Volume
- 108
- Issue
- 8
- Pages
- 985-995
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC3319502
- OpenAlex
- W2129909114
- Cited by
- 387
- References
- 43
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 25 · 2023: 22 · 2022: 34 · 2021: 17 · 2020: 21 · 2019: 30 · 2018: 26 · 2017: 30 · 2016: 21 · 2015: 28 · 2014: 25 · 2013: 29 · 2012: 31
- FWCI
- 14.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- LillOA (Université de Lille (University Of Lille)) (submittedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- M2 macrophages, CD206, CD68, phagocytosis, cholesterol efflux, ABCA1, apolipoprotein E, liver X receptor alpha, PPARγ, 15-lipoxygenase, foam cells, macrophage heterogeneity, opsonins
- MeSH terms
- Liver X Receptors, Cell Differentiation, Cells, Cultured, Cholesterol, Humans, Leukocytes, Mononuclear, Macrophages, Phagocytosis, Genetic Predisposition to Disease, PPAR gamma, Orphan Nuclear Receptors, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review